Valeant Pharmaceuticals 'Still Moving' Despite Lack Of Headlines, Analyst Says
April 27, 2015 at 08:30 AM EDT
In a report published Monday, Barclays analysts maintained an Overweight rating on Valeant Pharmaceuticals International Inc (NYSE: ...
